8225 — China Health Cashflow Statement
0.000.00%
- HK$99.54m
- HK$91.01m
- CNY21.43m
Annual cashflow statement for China Health, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 32.5 | 70.8 | 42.5 | -15.8 | -58.2 |
Depreciation | |||||
Non-Cash Items | 0.163 | -15.7 | 0.139 | 9.78 | 59.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -34.4 | -36.3 | -53.1 | 0.74 | -0.234 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.485 | 19.1 | -10.3 | -5.16 | 1.12 |
Capital Expenditures | -0.001 | 0 | — | — | -6 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.009 | -12 | 6.96 | -2.15 | 4.96 |
Acquisition of Business | |||||
Sale of Business | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.008 | -12 | 6.96 | -2.15 | -1.04 |
Financing Cash Flow Items | -0.068 | -0.061 | -0.015 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.068 | 0.593 | -1.51 | 0 | — |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.545 | 7.73 | -4.83 | -7.3 | 0.08 |